OBJECTIVE: A study was undertaken to investigate the association of intellectual and physical activity with biomarkers of Alzheimer disease (AD) pathophysiology and cognition in a nondemented elderly population. The biomarkers evaluated were brain Aβ load via Pittsburgh compound B (PiB)-positron emission tomography (PET), neuronal dysfunction via (18) F-fluorodeoxyglucose (FDG)-PET, and neurodegeneration via structural magnetic resonance imaging (MRI). METHODS: We studied 515 nondemented (428 cognitively normal and 87 mild cognitive impairment) participants in the population-based Mayo Clinic Study of Aging who completed a 3T MRI, PET scans, and APOE genotype, and had lifestyle activity measures and cognition data available. The imaging measures computed were global PiB-PET uptake, and global FDG-PET and MRI based hippocampal volume. We consolidated activity variables into lifetime intellectual, current intellectual, and current physical activities. We used a global cognitive z score as a measure of cognition. We applied 2 independent methods-partial correlation analysis adjusted for age and gender and path analysis using structural equations-to evaluate the associations between lifestyle activities, imaging biomarkers, and global cognition. RESULTS: None of the lifestyle variables were correlated with the biomarkers, and the path associations between lifestyle variables and biomarkers were not significant (p > 0.05). Conversely, all the biomarkers were correlated with global cognitive z score (p < 0.05), and the path associations between (lifetime and current) intellectual activities and global z score were significant (p < 0.01). INTERPRETATION: Intellectual and physical activity lifestyle factors were not associated with AD biomarkers, but intellectual lifestyle factors explained variability in the cognitive performance in this nondemented population. This study provides evidence that lifestyle activities may delay the onset of dementia but do not significantly influence the expression of AD pathophysiology.
OBJECTIVE: A study was undertaken to investigate the association of intellectual and physical activity with biomarkers of Alzheimer disease (AD) pathophysiology and cognition in a nondemented elderly population. The biomarkers evaluated were brain Aβ load via Pittsburgh compound B (PiB)-positron emission tomography (PET), neuronal dysfunction via (18) F-fluorodeoxyglucose (FDG)-PET, and neurodegeneration via structural magnetic resonance imaging (MRI). METHODS: We studied 515 nondemented (428 cognitively normal and 87 mild cognitive impairment) participants in the population-based Mayo Clinic Study of Aging who completed a 3T MRI, PET scans, and APOE genotype, and had lifestyle activity measures and cognition data available. The imaging measures computed were global PiB-PET uptake, and global FDG-PET and MRI based hippocampal volume. We consolidated activity variables into lifetime intellectual, current intellectual, and current physical activities. We used a global cognitive z score as a measure of cognition. We applied 2 independent methods-partial correlation analysis adjusted for age and gender and path analysis using structural equations-to evaluate the associations between lifestyle activities, imaging biomarkers, and global cognition. RESULTS: None of the lifestyle variables were correlated with the biomarkers, and the path associations between lifestyle variables and biomarkers were not significant (p > 0.05). Conversely, all the biomarkers were correlated with global cognitive z score (p < 0.05), and the path associations between (lifetime and current) intellectual activities and global z score were significant (p < 0.01). INTERPRETATION: Intellectual and physical activity lifestyle factors were not associated with AD biomarkers, but intellectual lifestyle factors explained variability in the cognitive performance in this nondemented population. This study provides evidence that lifestyle activities may delay the onset of dementia but do not significantly influence the expression of AD pathophysiology.
Authors: Susan M Landau; Shawn M Marks; Elizabeth C Mormino; Gil D Rabinovici; Hwamee Oh; James P O'Neil; Robert S Wilson; William J Jagust Journal: Arch Neurol Date: 2012-05
Authors: E C Mormino; J T Kluth; C M Madison; G D Rabinovici; S L Baker; B L Miller; R A Koeppe; C A Mathis; M W Weiner; W J Jagust Journal: Brain Date: 2008-11-28 Impact factor: 13.501
Authors: Kelvin Y Liang; Mark A Mintun; Anne M Fagan; Alison M Goate; Julie M Bugg; David M Holtzman; John C Morris; Denise Head Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett Journal: JAMA Date: 2002-02-13 Impact factor: 56.272
Authors: Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski Journal: Lancet Neurol Date: 2010-01 Impact factor: 44.182
Authors: Gary W Arendash; Marcos F Garcia; David A Costa; Jennifer R Cracchiolo; Inge M Wefes; H Potter Journal: Neuroreport Date: 2004-08-06 Impact factor: 1.837
Authors: Yonas E Geda; Rosebud O Roberts; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Bradley F Boeve; Eric G Tangalos; Ronald C Petersen; Walter A Rocca Journal: Arch Neurol Date: 2010-01
Authors: Carla M Yuede; Scott D Zimmerman; Hongxin Dong; Matthew J Kling; Adam W Bero; David M Holtzman; Benjamin F Timson; John G Csernansky Journal: Neurobiol Dis Date: 2009-06-12 Impact factor: 5.996
Authors: Prashanthi Vemuri; Stephen D Weigand; Scott A Przybelski; David S Knopman; Glenn E Smith; John Q Trojanowski; Leslie M Shaw; Charlie S Decarli; Owen Carmichael; Matt A Bernstein; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack Journal: Brain Date: 2011-04-07 Impact factor: 13.501
Authors: Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield Journal: Biochim Biophys Acta Date: 2013-10-09
Authors: C A Raji; H Eyre; S H Wei; D E Bredesen; S Moylan; M Law; G Small; P M Thompson; R M Friedlander; D H Silverman; B T Baune; T A Hoang; N Salamon; A W Toga; M W Vernooij Journal: AJNR Am J Neuroradiol Date: 2015-06-04 Impact factor: 3.825
Authors: Christopher M Gidicsin; Jacqueline E Maye; Joseph J Locascio; Lesley C Pepin; Marlie Philiossaint; J Alex Becker; Alayna P Younger; Maria Dekhtyar; Aaron P Schultz; Rebecca E Amariglio; Gad A Marshall; Dorene M Rentz; Trey Hedden; Reisa A Sperling; Keith A Johnson Journal: Neurology Date: 2015-06-10 Impact factor: 9.910
Authors: Andreea M Rawlings; A Richey Sharrett; Thomas H Mosley; Dean F Wong; David S Knopman; Rebecca F Gottesman Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Stefanie Schreiber; Jacob Vogel; Henry D Schwimmer; Shawn M Marks; Frank Schreiber; William Jagust Journal: Neurobiol Aging Date: 2016-01-30 Impact factor: 4.673